Roboz Surgical Instrument公司一直为研究人员提供专门的、手工制作的外科器械，以满足他们独特的需求。Roboz Surgical Instrument公司是外科器械和相关产品的领先设计师和开发商，产品被世界各地的医疗保健和研究专业人士使用。

When Otto Roboz started the Roboz Surgical Instrument Company in 1953, his goal was to provide researchers with specialized, hand-crafted surgical instruments designed to meet their unique demands.  Since then, Roboz Surgical has grown into one of the life science market’s leading sources of quality surgical instruments. Although the work of the research community has changed quite a bit over the last 60 years, Roboz Surgical, through constant innovation, continues to provide the highest-quality instruments and unparalleled service, to meet and exceed all of our customers’ needs.

Today Roboz Surgical Instrument Company is a leading designer and developer of surgical instruments and related products. Our products are used by healthcare and research professionals worldwide. Throughout our history of over sixty years , the Roboz name has been synonymous with quality.

Roboz Surgical Instrument公司主要产品：

Bone Instruments

Clips & Clamps

General Micro Dissecting

Instrument Care and

Handling

Instrument Services

Misc. Instruments

Retractors

Scalpels

Scissors

Tweezers & Forceps

Vascular Access

Wound Closures

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

艾美捷科技代理Yakult Pharma品牌。Yakult Pharma为工业用户、发酵行业和实验室提供高品质酶制剂产品。

艾美捷科技特约代理Avidity Biosciences公司产品。

Avidity Biosciences公司位于美国加州La Jolla，是一家专门从事抗体寡核苷酸结合物（AOC™）技术开发的生物技术公司，此项技术结合了单抗组织选择性和寡核苷酸疗法的精确性，克服了寡核苷酸给药屏障。

Avidity Biosciences is a privately-held biotech company pioneering Antibody Oligonucleotide Conjugates (AOC™). AOCs combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapeutics to overcome barriers to the delivery of oligonucleotides and target genetic drivers of disease.

Antibody oligonucleotide conjugate (AOC™) technology

Avidity’s antibody oligonucleotide conjugate (AOC™) technology utilizes antibodies to target cells and tissues of interest and facilitate the uptake and internalization of oligonucleotide payloads. By combining the cellular and tissue selectivity of antibodies with the selectivity and efficiency of oligo-based approaches, Avidity has demonstrated modulation of disease-related RNAs in diverse cell types and tissues including muscle, heart, liver, tumors and immune cells.